<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39207648</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2509-2723</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Aug</Month><Day>29</Day></PubDate></JournalIssue><Title>GeroScience</Title><ISOAbbreviation>Geroscience</ISOAbbreviation></Journal><ArticleTitle>Human herpesvirus reactivation and its potential role in the pathogenesis of post-acute sequelae of SARS-CoV-2 infection.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11357-024-01323-9</ELocationID><Abstract><AbstractText>The emergence of SARS-CoV-2 has precipitated a global pandemic with substantial long-term health implications, including the condition known as post-acute sequelae of SARS-CoV-2 infection (PASC), commonly referred to as Long COVID. PASC is marked by persistent symptoms such as fatigue, neurological issues, and autonomic dysfunction that persist for months beyond the acute phase of COVID-19. This review examines the potential role of herpesvirus reactivation, specifically Epstein-Barr virus (EBV) and cytomegalovirus (CMV), in the pathogenesis of PASC. Elevated antibody titers and specific T cell responses suggest recent herpesvirus reactivation in some PASC patients, although viremia is not consistently detected. SARS-CoV-2 exhibits endothelial trophism, directly affecting the vascular endothelium and contributing to microvascular pathologies. These pathologies are significant in PASC, where microvascular dysfunction may underlie various chronic symptoms. Similarly, herpesviruses like CMV also exhibit endothelial trophism, which may exacerbate endothelial damage when reactivated. Evidence suggests that EBV and CMV reactivation could indirectly contribute to the immune dysregulation, immunosenescence, and autoimmune responses observed in PASC. Additionally, EBV may play a role in the genesis of neurological symptoms through creating mitochondrial dysfunction, though direct confirmation remains elusive. The reviewed evidence suggests that while herpesviruses may not play a direct role in the pathogenesis of PASC, their potential indirect effects, especially in the context of endothelial involvement, warrant further investigation.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>G&#xe1;sp&#xe1;r</LastName><ForeName>Zs&#xf3;fia</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>School of PhD Studies, Semmelweis University, &#xdc;ll&#x151;i Street 26, 1085, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>South Pest Central Hospital, National Institute of Haematology and Infectious Diseases, Albert Fl&#xf3;ri&#xe1;n Street 5-7, 1097, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szab&#xf3;</LastName><ForeName>B&#xe1;lint Gergely</ForeName><Initials>BG</Initials><Identifier Source="ORCID">0000-0003-1775-1356</Identifier><AffiliationInfo><Affiliation>School of PhD Studies, Semmelweis University, &#xdc;ll&#x151;i Street 26, 1085, Budapest, Hungary. szabo.balint.gergely@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>South Pest Central Hospital, National Institute of Haematology and Infectious Diseases, Albert Fl&#xf3;ri&#xe1;n Street 5-7, 1097, Budapest, Hungary. szabo.balint.gergely@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departmental Group of Infectious Diseases, Department of Internal Medicine and Haematology, Semmelweis University, Albert Fl&#xf3;ri&#xe1;n Street 5-7, 1097, Budapest, Hungary. szabo.balint.gergely@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cegl&#xe9;di</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>South Pest Central Hospital, National Institute of Haematology and Infectious Diseases, Albert Fl&#xf3;ri&#xe1;n Street 5-7, 1097, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lakatos</LastName><ForeName>Botond</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>School of PhD Studies, Semmelweis University, &#xdc;ll&#x151;i Street 26, 1085, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>South Pest Central Hospital, National Institute of Haematology and Infectious Diseases, Albert Fl&#xf3;ri&#xe1;n Street 5-7, 1097, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departmental Group of Infectious Diseases, Department of Internal Medicine and Haematology, Semmelweis University, Albert Fl&#xf3;ri&#xe1;n Street 5-7, 1097, Budapest, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Geroscience</MedlineTA><NlmUniqueID>101686284</NlmUniqueID><ISSNLinking>2509-2723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brain fog</Keyword><Keyword MajorTopicYN="N">CMV</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">EBV</Keyword><Keyword MajorTopicYN="N">Herpesvirus</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">POTS</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>29</Day><Hour>11</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39207648</ArticleId><ArticleId IdType="doi">10.1007/s11357-024-01323-9</ArticleId><ArticleId IdType="pii">10.1007/s11357-024-01323-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kitamura N, Abbas K, Nathwani D. Public health and social measures to mitigate the health and economic impact of the COVID-19 pandemic in Turkey, Egypt, Ukraine, Kazakhstan, and Poland during 2020&#x2013;2021: situational analysis. BMC Public Health. 2022;22:991. https://doi.org/10.1186/s12889-022-13411-6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-13411-6</ArticleId><ArticleId IdType="pubmed">35578330</ArticleId><ArticleId IdType="pmc">9110083</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO COVID-19 dashboard. https://data.who.int/dashboards/covid19/deaths?n=o . Accessed 07/08/2024.</Citation></Reference><Reference><Citation>Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D, Fain MJ. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience. 2020;42:505&#x2013;14. https://doi.org/10.1007/s11357-020-00186-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-020-00186-0</ArticleId><ArticleId IdType="pubmed">32274617</ArticleId><ArticleId IdType="pmc">7145538</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterfi A, Meszaros A, Szarvas Z, Penzes M, Fekete M, Feher A, Lehoczki A, Csipo T, Fazekas-Pongor V. Comorbidities and increased mortality of COVID-19 among the elderly: a systematic review. Physiol Int. 2022. https://doi.org/10.1556/2060.2022.00206 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1556/2060.2022.00206</ArticleId><ArticleId IdType="pubmed">35575986</ArticleId></ArticleIdList></Reference><Reference><Citation>Fekete M, Szarvas Z, Fazekas-Pongor V, Feher A, Dosa N, Lehoczki A, Tarantini S, Varga JT. COVID-19 infection in patients with chronic obstructive pulmonary disease: From pathophysiology to therapy. Mini-review Physiol Int. 2022. https://doi.org/10.1556/2060.2022.00172 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1556/2060.2022.00172</ArticleId><ArticleId IdType="pubmed">35230261</ArticleId></ArticleIdList></Reference><Reference><Citation>Feher A, Szarvas Z, Lehoczki A, Fekete M, Fazekas-Pongor V. Co-infections in COVID-19 patients and correlation with mortality rate. Minireview Physiol Int. 2022. https://doi.org/10.1556/2060.2022.00015 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1556/2060.2022.00015</ArticleId><ArticleId IdType="pubmed">35230261</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention: Provisional Death Counts for Coronavirus Disease (COVID-19) https://www.cdc.gov/nchs/nvss/vsrr/covid19/index.htm .Accessed on 06/23/2024.</Citation></Reference><Reference><Citation>Russell SJ, Parker K, Lehoczki A, Lieberman D, Partha IS, Scott SJ, Phillips LR, Fain MJ, Nikolich JZ. Post-acute sequelae of SARS-CoV-2 infection (long COVID) in older adults. Geroscience. 2024. https://doi.org/10.1007/s11357-024-01227-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-024-01227-8</ArticleId><ArticleId IdType="pubmed">38874693</ArticleId></ArticleIdList></Reference><Reference><Citation>Witkowski JM, Fulop T, Bryl E. Immunosenescence and COVID-19. Mech Ageing Dev. 2022;204: 111672. https://doi.org/10.1016/j.mad.2022.111672 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2022.111672</ArticleId><ArticleId IdType="pubmed">35378106</ArticleId><ArticleId IdType="pmc">8975602</ArticleId></ArticleIdList></Reference><Reference><Citation>Promislow DEL. A geroscience perspective on COVID-19 Mortality. J Gerontol A Biol Sci Med Sci. 2020;75:e30&#x2013;3. https://doi.org/10.1093/gerona/glaa094 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glaa094</ArticleId><ArticleId IdType="pubmed">32300796</ArticleId><ArticleId IdType="pmc">7184466</ArticleId></ArticleIdList></Reference><Reference><Citation>Fekete M, Major D, Feher A, Fazekas-Pongor V, Lehoczki A. Geroscience and pathology: a new frontier in understanding age-related diseases. Pathol Oncol Res. 2024. https://doi.org/10.3389/pore.2024.1611623</Citation></Reference><Reference><Citation>WHO. Post COVID-19 condition (Long COVID). https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition . Accessed at 2024.06.02.</Citation></Reference><Reference><Citation>Bhattacharjee N, Sarkar P, Sarkar T. Beyond the acute illness: exploring long COVID and its impact on multiple organ systems. Physiol Int. 2023;110:291&#x2013;310. https://doi.org/10.1556/2060.2023.00256 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1556/2060.2023.00256</ArticleId><ArticleId IdType="pubmed">37943302</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110:3484&#x2013;96. https://doi.org/10.1016/j.neuron.2022.10.006 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId><ArticleId IdType="pmc">9537254</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansell V, Hall Dykgraaf S, Kidd M, Goodyear-Smith F. Long COVID and older people. Lancet Healthy Longev. 2022;3:e849&#x2013;54. https://doi.org/10.1016/S2666-7568(22)00245-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-7568(22)00245-8</ArticleId><ArticleId IdType="pubmed">36480981</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro F, Belati A, Tulone O, Diella L, Fiore Bavaro D, Bonica R, Genna V, Smith L, Trott M, Bruyere O, et al. Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients. Intern Emerg Med. 2023;18:1573&#x2013;81. https://doi.org/10.1007/s11739-022-03164-w .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-022-03164-w</ArticleId><ArticleId IdType="pubmed">36449260</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Julg B, Mohandas S, Bradfute SB, Force RMPT. Viral persistence, reactivation, and mechanisms of long COVID. Elife. 2023;12. https://doi.org/10.7554/eLife.86015 .</Citation></Reference><Reference><Citation>Saito S, Shahbaz S, Luo X, Osman M, Redmond D, Cohen Tervaert JW, Li L, Elahi S. Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome. Front Immunol. 2024;15:1341843. https://doi.org/10.3389/fimmu.2024.1341843 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1341843</ArticleId><ArticleId IdType="pubmed">38304426</ArticleId><ArticleId IdType="pmc">10830702</ArticleId></ArticleIdList></Reference><Reference><Citation>Elizalde-Diaz JP, Miranda-Narvaez CL, Martinez-Lazcano JC, Martinez-Martinez E. The relationship between chronic immune response and neurodegenerative damage in long COVID-19. Front Immunol. 2022;13:1039427. https://doi.org/10.3389/fimmu.2022.1039427 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1039427</ArticleId><ArticleId IdType="pubmed">36591299</ArticleId><ArticleId IdType="pmc">9800881</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R, Banerjee A, Baker MR, Dani M, Ford E, Hull JH, Lim PB, McNarry M, Morten K, O&#x2019;Sullivan O, et al. Long COVID: mechanisms, risk factors and recovery. Exp Physiol. 2023;108:12&#x2013;27. https://doi.org/10.1113/EP090802 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP090802</ArticleId><ArticleId IdType="pubmed">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello-Chavolla OY, Fermin-Martinez CA, Ramirez-Garcia D, Vargas-Vazquez A, Fernandez-Chirino L, Basile-Alvarez MR, Sanchez-Castro P, Nunez-Luna A, Antonio-Villa NE. Prevalence and determinants of post-acute sequelae after SARS-CoV-2 infection (Long COVID) among adults in Mexico during 2022: a retrospective analysis of nationally representative data. Lancet Reg Health Am. 2024;30:100688. https://doi.org/10.1016/j.lana.2024.100688 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2024.100688</ArticleId><ArticleId IdType="pubmed">38327277</ArticleId><ArticleId IdType="pmc">10847769</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S, Rahman O. Postintensive care syndrome. In: StatPearls. Treasure Island (FL). StatPearls Publishing. 2024. https://www.ncbi.nlm.nih.gov/books/NBK558964/ . Accessed 07/08/2024.</Citation></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9:129. https://doi.org/10.1016/S2213-2600(21)00031-X .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId><ArticleId IdType="pmc">7832375</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas LS, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;31. https://doi.org/10.1038/s41591-021-01292-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId><ArticleId IdType="pmc">7611399</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan K, Lin Y, Prewitt KM, Potter DA. Multidisciplinary approach to brain fog and related persisting symptoms post COVID-19. J Health Serv Psychol. 2022;48:31&#x2013;8. https://doi.org/10.1007/s42843-022-00056-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42843-022-00056-7</ArticleId><ArticleId IdType="pubmed">35128461</ArticleId><ArticleId IdType="pmc">8809226</ArticleId></ArticleIdList></Reference><Reference><Citation>Campen C, Rowe PC, Visser FC. Orthostatic symptoms and reductions in cerebral blood flow in long-haul COVID-19 patients: similarities with myalgic encephalomyelitis/chronic fatigue syndrome. Medicina (Kaunas). 2021;58. https://doi.org/10.3390/medicina58010028 .</Citation></Reference><Reference><Citation>Campen C, Visser FC. Long-Haul COVID patients: prevalence of POTS are reduced but cerebral blood flow abnormalities remain abnormal with longer disease duration. Healthcare (Basel). 2022;10. https://doi.org/10.3390/healthcare10102105 .</Citation></Reference><Reference><Citation>van Campen C, Visser FC. Orthostatic intolerance in long-haul COVID after SARS-CoV-2: a case-control comparison with post-EBV and insidious-onset myalgic encephalomyelitis/chronic fatigue syndrome patients. Healthcare (Basel). 2022;10. https://doi.org/10.3390/healthcare10102058 .</Citation></Reference><Reference><Citation>Chilunga FP, Appelman B, van Vugt M, Kalverda K, Smeele P, van Es J, Wiersinga WJ, Rostila M, Prins M, Stronks K, et al. Differences in incidence, nature of symptoms, and duration of long COVID among hospitalised migrant and non-migrant patients in the Netherlands: a retrospective cohort study. Lancet Reg Health Eur. 2023;29:100630. https://doi.org/10.1016/j.lanepe.2023.100630 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100630</ArticleId><ArticleId IdType="pubmed">37261215</ArticleId><ArticleId IdType="pmc">10079482</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi C, Osborne T, Bailey R, Cooper A, Hollinghurst JP, Akbari A, Crowder R, Peters H, Law RJ, Lewis R, et al. Impact of COVID-19 pandemic on incidence of long-term conditions in Wales: a population data linkage study using primary and secondary care health records. Br J Gen Pract. 2023;73:e332&#x2013;9. https://doi.org/10.3399/BJGP.2022.0353 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP.2022.0353</ArticleId><ArticleId IdType="pubmed">37105743</ArticleId><ArticleId IdType="pmc">9997656</ArticleId></ArticleIdList></Reference><Reference><Citation>Frallonardo L, Segala FV, Chhaganlal KD, Yelshazly M, Novara R, Cotugno S, Guido G, Papagni R, Colpani A, De Vito A, et al. Incidence and burden of long COVID in Africa: a systematic review and meta-analysis. Sci Rep. 2023;13:21482. https://doi.org/10.1038/s41598-023-48258-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-48258-3</ArticleId><ArticleId IdType="pubmed">38057338</ArticleId><ArticleId IdType="pmc">10700349</ArticleId></ArticleIdList></Reference><Reference><Citation>Beretta S, Cristillo V, Camera G, Morotti Colleoni C, Pellitteri G, Viti B, Bianchi E, Gipponi S, Grimoldi M, Valente M, et al. Incidence and long-term functional outcome of neurologic disorders in hospitalized patients with COVID-19 infected with pre-omicron variants. Neurology. 2023;101:e892&#x2013;903. https://doi.org/10.1212/WNL.0000000000207534 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000207534</ArticleId><ArticleId IdType="pubmed">37414564</ArticleId><ArticleId IdType="pmc">10501088</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai J, Grace A, Espinoza R, Kurian A. Incidence of long COVID and associated psychosocial characteristics in a large U.S. city. Soc Psychiatry Psychiatr Epidemiol. 2023. https://doi.org/10.1007/s00127-023-02548-3 .</Citation></Reference><Reference><Citation>Sedgley R, Winer-Jones J, Bonafede M. Long COVID incidence in a large US ambulatory electronic health record system. Am J Epidemiol. 2023;192:1350&#x2013;7. https://doi.org/10.1093/aje/kwad095 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwad095</ArticleId><ArticleId IdType="pubmed">37073410</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs MM, Evans E, Ellis C. Racial, ethnic, and sex disparities in the incidence and cognitive symptomology of long COVID-19. J Natl Med Assoc. 2023;115:233&#x2013;43. https://doi.org/10.1016/j.jnma.2023.01.016 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnma.2023.01.016</ArticleId><ArticleId IdType="pubmed">36792456</ArticleId></ArticleIdList></Reference><Reference><Citation>Gado K, Kovacs AK, Domjan G, Nagy ZZ, Bednarik GD. COVID-19 and the elderly. Physiol Int. 2022. https://doi.org/10.1556/2060.2022.00203 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1556/2060.2022.00203</ArticleId><ArticleId IdType="pubmed">35895570</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung KW, Baye F, Baik SH, Zheng Z, McDonald CJ. Prevalence and characteristics of long COVID in elderly patients: an observational cohort study of over 2 million adults in the US. PLoS Med. 2023;20:e1004194. https://doi.org/10.1371/journal.pmed.1004194 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004194</ArticleId><ArticleId IdType="pubmed">37068113</ArticleId><ArticleId IdType="pmc">10150975</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen K, Ren S, Heath K, Dasmarinas MC, Jubilo KG, Guo Y, Lipsitch M, Daugherty SE. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2022;376:e068414. https://doi.org/10.1136/bmj-2021-068414 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068414</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanbehzadeh S, Zanjari N, Yassin M, Yassin Z, Tavahomi M. Association between long COVID, functional activity, and health-related quality of life in older adults. BMC Geriatr. 2023;23:40. https://doi.org/10.1186/s12877-023-03757-w .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-023-03757-w</ArticleId><ArticleId IdType="pubmed">36690948</ArticleId><ArticleId IdType="pmc">9868494</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deveau TM, Munter SE, Ryder D, Buck A, Beck-Engeser G, Chan F, Lu S, Goldberg SA, Hoh R, et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Invest. 2023;133. https://doi.org/10.1172/JCI163669 .</Citation></Reference><Reference><Citation>Altmann DM, Whettlock EM, Liu S, Arachchillage DJ, Boyton RJ. The immunology of long COVID. Nat Rev Immunol. 2023;23:618&#x2013;34. https://doi.org/10.1038/s41577-023-00904-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-023-00904-7</ArticleId><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MH, Perl DP, Steiner J, Pasternack N, Li W, Maric D, Safavi F, Horkayne-Szakaly I, Jones R, Stram MN, et al. Neurovascular injury with complement activation and inflammation in COVID-19. Brain. 2022;145:2555&#x2013;68. https://doi.org/10.1093/brain/awac151 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac151</ArticleId><ArticleId IdType="pubmed">35788639</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao H, Deng X, Qiu L, Qu Y, Chiu Y, Chen F, Xia S, Muenzel C, Ge T, Zhang Z, et al. SARS-CoV-2 induces blood-brain barrier and choroid plexus barrier impairments and vascular inflammation in mice. J Med Virol. 2024;96:e29671. https://doi.org/10.1002/jmv.29671 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.29671</ArticleId><ArticleId IdType="pubmed">38747003</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulli A, Gotelli E, Bica PF, Schiavetti I, Pizzorni C, Aloe T, Grosso M, Barisione E, Paolino S, Smith V, Cutolo M. Detailed videocapillaroscopic microvascular changes detectable in adult COVID-19 survivors. Microvasc Res. 2022;142:104361. https://doi.org/10.1016/j.mvr.2022.104361 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2022.104361</ArticleId><ArticleId IdType="pubmed">35339493</ArticleId><ArticleId IdType="pmc">8942583</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolai L, Kaiser R, Stark K. Thromboinflammation in long COVID-the elusive key to postinfection sequelae? J Thromb Haemost. 2023;21:2020&#x2013;31. https://doi.org/10.1016/j.jtha.2023.04.039 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtha.2023.04.039</ArticleId><ArticleId IdType="pubmed">37178769</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene C, Connolly R, Brennan D, Laffan A, O&#x2019;Keeffe E, Zaporojan L, O&#x2019;Callaghan J, Thomson B, Connolly E, Argue R, et al. Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. 2024. https://doi.org/10.1038/s41593-024-01576-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-024-01576-9</ArticleId><ArticleId IdType="pubmed">38627595</ArticleId><ArticleId IdType="pmc">11088991</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimarco V, Izzo R, Zanforlin A, Tursi F, Scarpelli F, Santus P, Pennisi A, Pelaia G, Mussi C, Mininni S, et al. Endothelial dysfunction in long-COVID: new insights from the nationwide multicenter LINCOLN Study. Pharmacol Res. 2022;185:106486. https://doi.org/10.1016/j.phrs.2022.106486 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2022.106486</ArticleId><ArticleId IdType="pubmed">36206959</ArticleId><ArticleId IdType="pmc">9531936</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimarco V, Izzo R, Mone P, Trimarco B, Santulli G. Targeting endothelial dysfunction and oxidative stress in Long-COVID. Pharmacol Res. 2022;184:106451. https://doi.org/10.1016/j.phrs.2022.106451 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2022.106451</ArticleId><ArticleId IdType="pubmed">36108875</ArticleId><ArticleId IdType="pmc">9467917</ArticleId></ArticleIdList></Reference><Reference><Citation>Seitz A, Ong P. Endothelial dysfunction in COVID-19: a potential predictor of long-COVID? Int J Cardiol. 2022;349:155&#x2013;6. https://doi.org/10.1016/j.ijcard.2021.11.051 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2021.11.051</ArticleId><ArticleId IdType="pubmed">34838682</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliou AG, Vrettou CS, Keskinidou C, Dimopoulou I, Kotanidou A, Orfanos SE. Endotheliopathy in acute COVID-19 and long COVID. Int J Mol Sci. 2023;24. https://doi.org/10.3390/ijms24098237</Citation></Reference><Reference><Citation>Prasad M, Leon M, Lerman LO, Lerman A. Viral endothelial dysfunction: a unifying mechanism for COVID-19. Mayo Clin Proc. 2021;96:3099&#x2013;108. https://doi.org/10.1016/j.mayocp.2021.06.027 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.06.027</ArticleId><ArticleId IdType="pubmed">34863398</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro L, Zaccone V, Falsetti L, Ruggieri V, Danese M, Miro C, Di Giorgio A, Nesci A, D'Alessandro A, Moroncini G, Santoliquido A. Role of endothelium in cardiovascular sequelae of long COVID. Biomedicines. 2023;11. https://doi.org/10.3390/biomedicines11082239 .</Citation></Reference><Reference><Citation>Sabioni L, De Lorenzo A, Lamas C, Muccillo F, Castro-Faria-Neto HC, Estato V, Tibirica E. Systemic microvascular endothelial dysfunction and disease severity in COVID-19 patients: evaluation by laser Doppler perfusion monitoring and cytokine/chemokine analysis. Microvasc Res. 2020;134:104119. https://doi.org/10.1016/j.mvr.2020.104119 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2020.104119</ArticleId><ArticleId IdType="pubmed">33278457</ArticleId><ArticleId IdType="pmc">7710468</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruhl L, Pink I, Kuhne JF, Beushausen K, Keil J, Christoph S, Sauer A, Boblitz L, Schmidt J, David S, et al. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks. Signal Transduct Target Ther. 2021;6:418. https://doi.org/10.1038/s41392-021-00819-6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00819-6</ArticleId><ArticleId IdType="pubmed">34893580</ArticleId><ArticleId IdType="pmc">8661333</ArticleId></ArticleIdList></Reference><Reference><Citation>Owens CD, Bonin Pinto C, Detwiler S, Olay L, Pinaffi-Langley A, Mukli P, Peterfi A, Szarvas Z, James JA, Galvan V, et al. Neurovascular coupling impairment as a mechanism for cognitive deficits in COVID-19. Brain Commun. 2024;6:fcae080. https://doi.org/10.1093/braincomms/fcae080 .</Citation></Reference><Reference><Citation>Owens CD, Pinto CB, Detwiler S, Mukli P, Peterfi A, Szarvas Z, Hoffmeister JR, Galindo J, Noori J, Kirkpatrick AC, et al. Cerebral small vessel disease pathology in COVID-19 patients: a systematic review. Ageing Res Rev. 2023;88:101962. https://doi.org/10.1016/j.arr.2023.101962 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2023.101962</ArticleId><ArticleId IdType="pubmed">37224885</ArticleId><ArticleId IdType="pmc">10202464</ArticleId></ArticleIdList></Reference><Reference><Citation>Owens CD, Bonin Pinto C, Mukli P, Szarvas Z, Peterfi A, Detwiler S, Olay L, Olson AL, Li G, Galvan V, et al. Vascular mechanisms leading to progression of mild cognitive impairment to dementia after COVID-19: protocol and methodology of a prospective longitudinal observational study. PLoS ONE. 2023;18:e0289508. https://doi.org/10.1371/journal.pone.0289508 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0289508</ArticleId><ArticleId IdType="pubmed">37535668</ArticleId><ArticleId IdType="pmc">10399897</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkpatrick A, Delpirou NC, Husain F, Xu C, Vincent A, Yabluchanskiy A, Csiszar A, Ungvari Z, Scott J, Prodan C. MCI patients with COVID-19 have increased progression to dementia at 18 months (S39. 010). Neurology. 2023;100.</Citation></Reference><Reference><Citation>Oikonomou E, Souvaliotis N, Lampsas S, Siasos G, Poulakou G, Theofilis P, Papaioannou TG, Haidich AB, Tsaousi G, Ntousopoulos V, et al. Endothelial dysfunction in acute and long standing COVID-19: a prospective cohort study. Vascul Pharmacol. 2022;144:106975. https://doi.org/10.1016/j.vph.2022.106975 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2022.106975</ArticleId><ArticleId IdType="pubmed">35248780</ArticleId><ArticleId IdType="pmc">8893931</ArticleId></ArticleIdList></Reference><Reference><Citation>Moretta P, Maniscalco M, Papa A, Lanzillo A, Trojano L, Ambrosino P. Cognitive impairment and endothelial dysfunction in convalescent COVID-19 patients undergoing rehabilitation. Eur J Clin Invest. 2022;52:e13726. https://doi.org/10.1111/eci.13726 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13726</ArticleId><ArticleId IdType="pubmed">34921559</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaughlin M, Sanal-Hayes NEM, Hayes LD, Berry EC, Sculthorpe NF. People with long COVID and myalgic encephalomyelitis/chronic fatigue syndrome exhibit similarly impaired vascular function. Am J Med. 2023. https://doi.org/10.1016/j.amjmed.2023.09.013 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.09.013</ArticleId><ArticleId IdType="pubmed">38104642</ArticleId></ArticleIdList></Reference><Reference><Citation>Shabani Z, Liu J, Su H. Vascular Dysfunctions Contribute to the Long-Term Cognitive Deficits Following COVID-19. Biology (Basel). 2023;12. https://doi.org/10.3390/biology12081106 .</Citation></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, Ahmad A, Comerford C, Karampini E, Englert H, Byrne M, Bergin C, O&#x2019;Sullivan JM, et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. 2021;19:2546&#x2013;53. https://doi.org/10.1111/jth.15490 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Toth P, Tarantini S, Csiszar A, Ungvari Z. Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging. Am J Physiol Heart Circ Physiol. 2017;312:H1&#x2013;20. https://doi.org/10.1152/ajpheart.00581.2016 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00581.2016</ArticleId><ArticleId IdType="pubmed">27793855</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj D, Aenlle KK, Cohen J, Mathew A, Isler D, Pangeni RP, Nathanson L, Theoharides TC, Klimas NG. COVID-19 and long COVID: disruption of the neurovascular unit, blood-brain barrier, and tight junctions. Neuroscientist. 2023:10738584231194927. https://doi.org/10.1177/10738584231194927 .</Citation></Reference><Reference><Citation>Reinhold D, Farztdinov V, Yan Y, Meisel C, Sadlowski H, Kuhn J, Perschel FH, Endres M, Duzel E, Vielhaber S, et al. The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome. RNA and inflammation J Neuroinflammation. 2023;20:30. https://doi.org/10.1186/s12974-023-02711-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-023-02711-2</ArticleId><ArticleId IdType="pubmed">36759861</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyra ESNM, Barros-Aragao FGQ, De Felice FG, Ferreira ST. Inflammation at the crossroads of COVID-19, cognitive deficits and depression. Neuropharmacology. 2022;209:109023. https://doi.org/10.1016/j.neuropharm.2022.109023 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2022.109023</ArticleId></ArticleIdList></Reference><Reference><Citation>Duindam HB, Mengel D, Kox M, Gopfert JC, Kessels RPC, Synofzik M, Pickkers P, Abdo WF. Systemic inflammation relates to neuroaxonal damage associated with long-term cognitive dysfunction in COVID-19 patients. Brain Behav Immun. 2024;117:510&#x2013;20. https://doi.org/10.1016/j.bbi.2024.02.002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2024.02.002</ArticleId><ArticleId IdType="pubmed">38336025</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim HK, Al-Rubaye HT, Al-Hadrawi DS, Almulla AF, Maes M. Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study. Mol Psychiatry. 2023;28:564&#x2013;78. https://doi.org/10.1038/s41380-022-01836-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01836-9</ArticleId><ArticleId IdType="pubmed">36280755</ArticleId></ArticleIdList></Reference><Reference><Citation>Comeau D, Martin M, Robichaud GA, Chamard-Witkowski L. Neurological manifestations of post-acute sequelae of COVID-19: which liquid biomarker should we use? Front Neurol. 2023;14:1233192. https://doi.org/10.3389/fneur.2023.1233192 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1233192</ArticleId><ArticleId IdType="pubmed">37545721</ArticleId><ArticleId IdType="pmc">10400889</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuber-Champier A, Cionca A, Breville G, Voruz P, de Alcantara IJ, Allali G, Lalive PH, Benzakour L, Lovblad KO, Braillard O, et al. Acute TNFalpha levels predict cognitive impairment 6&#x2013;9 months after COVID-19 infection. Psychoneuroendocrinology. 2023;153:106104. https://doi.org/10.1016/j.psyneuen.2023.106104 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2023.106104</ArticleId><ArticleId IdType="pubmed">37104966</ArticleId><ArticleId IdType="pmc">10066791</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarius S, Pache F, Kortvelyessy P, Jelcic I, Stettner M, Franciotta D, Keller E, Neumann B, Ringelstein M, Senel M, et al. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. J Neuroinflammation. 2022;19:19. https://doi.org/10.1186/s12974-021-02339-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02339-0</ArticleId><ArticleId IdType="pubmed">35057809</ArticleId><ArticleId IdType="pmc">8771621</ArticleId></ArticleIdList></Reference><Reference><Citation>de Castro GS, Gama LR, Ramos AF, Gatti da Silva G, Teixeira AAS, Cunha-Neto E, de Souza HP, Marie SK, Talib LL, Coelho V, et al. Post-COVID-19 condition: systemic inflammation and low functional exercise capacity. Front Nutr. 2024;11:1295026. https://doi.org/10.3389/fnut.2024.1295026 .</Citation></Reference><Reference><Citation>Damiano RF, Rocca CCA, Serafim AP, Loftis JM, Talib LL, Pan PM, Cunha-Neto E, Kalil J, de Castro GS, Seelaender M, et al. Cognitive impairment in long-COVID and its association with persistent dysregulation in inflammatory markers. Front Immunol. 2023;14:1174020. https://doi.org/10.3389/fimmu.2023.1174020 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1174020</ArticleId><ArticleId IdType="pubmed">37287969</ArticleId><ArticleId IdType="pmc">10242059</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Castaneda A, Lu P, Geraghty AC, Song E, Lee MH, Wood J, Yalcin B, Taylor KR, Dutton S, Acosta-Alvarez L, et al. Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain. bioRxiv. 2022. https://doi.org/10.1101/2022.01.07.475453.</Citation></Reference><Reference><Citation>Boesl F, Goereci Y, Gerhard A, Bremer B, Raeder V, Schweitzer F, Hoppmann U, Behrens J, Bellmann-Strobl J, Paul F, et al. Cerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome. J Neurol. 2024;271:59&#x2013;70. https://doi.org/10.1007/s00415-023-12092-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-023-12092-4</ArticleId><ArticleId IdType="pubmed">37999770</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobinick E, Spengler RN, Ignatowski TA, Wassel M, Laborde S. Rapid improvement in severe long COVID following perispinal etanercept. Curr Med Res Opin. 2022;38:2013&#x2013;20. https://doi.org/10.1080/03007995.2022.2096351 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2096351</ArticleId><ArticleId IdType="pubmed">35791687</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H, Tian L, Marconi VC, Shafer R, McComsey GA, Miglis M, Yang P, Bonilla A, Eggert L, Geng LN. Low-dose naltrexone use for the management of post-acute sequelae of COVID-19. Int Immunopharmacol. 2023;124:110966. https://doi.org/10.1016/j.intimp.2023.110966 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2023.110966</ArticleId><ArticleId IdType="pubmed">37804660</ArticleId><ArticleId IdType="pmc">11028858</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens. 2021;10. https://doi.org/10.3390/pathogens10060763 .</Citation></Reference><Reference><Citation>Klein J, Wood J, Jaycox JR, Dhodapkar RM, Lu P, Gehlhausen JR, Tabachnikova A, Greene K, Tabacof L, Malik AA, et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623:139&#x2013;48. https://doi.org/10.1038/s41586-023-06651-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId><ArticleId IdType="pmc">10620090</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A, Vojdani E, Saidara E, Maes M. Persistent SARS-CoV-2 infection, EBV, HHV-6 and other factors may contribute to inflammation and autoimmunity in long COVID. Viruses. 2023;15. https://doi.org/10.3390/v15020400 .</Citation></Reference><Reference><Citation>Vojdani A, Almulla AF, Zhou B, Al-Hakeim HK, Maes M. Reactivation of herpesvirus type 6 and IgA/IgM-mediated responses to activin-A underpin long COVID, including affective symptoms and chronic fatigue syndrome. Acta Neuropsychiatr. 2024;36:172&#x2013;84. https://doi.org/10.1017/neu.2024.10 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/neu.2024.10</ArticleId><ArticleId IdType="pubmed">38571295</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrhofer J, Graninger M, Lettenmaier L, Schweighardt J, Gentile SA, Koidl L, Ret D, Stingl M, Puchhammer-Stockl E, Untersmayr E. Association between Epstein-Barr-Virus reactivation and development of Long-COVID fatigue. Allergy. 2023;78:297&#x2013;9. https://doi.org/10.1111/all.15471 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15471</ArticleId><ArticleId IdType="pubmed">35950630</ArticleId></ArticleIdList></Reference><Reference><Citation>Grahame-Clarke C, Chan NN, Andrew D, Ridgway GL, Betteridge DJ, Emery V, Colhoun HM, Vallance P. Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation. 2003;108:678&#x2013;83. https://doi.org/10.1161/01.CIR.0000084505.54603.C7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000084505.54603.C7</ArticleId><ArticleId IdType="pubmed">12900349</ArticleId></ArticleIdList></Reference><Reference><Citation>Weis M, Kledal TN, Lin KY, Panchal SN, Gao SZ, Valantine HA, Mocarski ES, Cooke JP. Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis. Circulation. 2004;109:500&#x2013;5. https://doi.org/10.1161/01.CIR.0000109692.16004.AF .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000109692.16004.AF</ArticleId><ArticleId IdType="pubmed">14732750</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoretonenko MV, Leskov IL, Jennings SR, Yurochko AD, Stokes KY. Cytomegalovirus infection leads to microvascular dysfunction and exacerbates hypercholesterolemia-induced responses. Am J Pathol. 2010;177:2134&#x2013;44. https://doi.org/10.2353/ajpath.2010.100307 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2010.100307</ArticleId><ArticleId IdType="pubmed">20802174</ArticleId><ArticleId IdType="pmc">2947306</ArticleId></ArticleIdList></Reference><Reference><Citation>Gombos RB, Wolan V, McDonald K, Hemmings DG. Impaired vascular function in mice with an active cytomegalovirus infection. Am J Physiol Heart Circ Physiol. 2009;296:H937-945. https://doi.org/10.1152/ajpheart.01027.2008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.01027.2008</ArticleId><ArticleId IdType="pubmed">19181963</ArticleId></ArticleIdList></Reference><Reference><Citation>Gombos RB, Brown JC, Teefy J, Gibeault RL, Conn KL, Schang LM, Hemmings DG. Vascular dysfunction in young, mid-aged and aged mice with latent cytomegalovirus infections. Am J Physiol Heart Circ Physiol. 2013;304:H183-194. https://doi.org/10.1152/ajpheart.00461.2012 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00461.2012</ArticleId><ArticleId IdType="pubmed">23125213</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng J, Ke Q, Jin Z, Wang H, Kocher O, Morgan JP, Zhang J, Crumpacker CS. Cytomegalovirus infection causes an increase of arterial blood pressure. PLoS Pathog. 2009;5:e1000427. https://doi.org/10.1371/journal.ppat.1000427 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000427</ArticleId><ArticleId IdType="pubmed">19436702</ArticleId><ArticleId IdType="pmc">2673691</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebedeva AM, Shpektor AV, Vasilieva EY, Margolis LB. Cytomegalovirus infection in cardiovascular diseases. Biochemistry (Mosc). 2018;83:1437&#x2013;47. https://doi.org/10.1134/S0006297918120027 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297918120027</ArticleId><ArticleId IdType="pubmed">30878019</ArticleId></ArticleIdList></Reference><Reference><Citation>Firth C, Harrison R, Ritchie S, Wardlaw J, Ferro CJ, Starr JM, Deary IJ, Moss P. Cytomegalovirus infection is associated with an increase in systolic blood pressure in older individuals. QJM. 2016;109:595&#x2013;600. https://doi.org/10.1093/qjmed/hcw026 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcw026</ArticleId><ArticleId IdType="pubmed">27071749</ArticleId><ArticleId IdType="pmc">5027953</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitley RJ. Herpesviruses. In: Whitley RJ. Medical Microbiology. 4th ed. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 68.</Citation></Reference><Reference><Citation>White DW, Suzanne Beard R, Barton ES. Immune modulation during latent herpesvirus infection. Immunol Rev. 2012;245:189&#x2013;208. https://doi.org/10.1111/j.1600-065X.2011.01074.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2011.01074.x</ArticleId><ArticleId IdType="pubmed">22168421</ArticleId><ArticleId IdType="pmc">3243940</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas SK, Gough G, Latchman DS, Coffin RS. Herpes simplex virus latency-associated transcript encodes a protein which greatly enhances virus growth, can compensate for deficiencies in immediate-early gene expression, and is likely to function during reactivation from virus latency. J Virol. 1999;73:6618&#x2013;25. https://doi.org/10.1128/JVI.73.8.6618-6625.1999 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.8.6618-6625.1999</ArticleId><ArticleId IdType="pubmed">10400759</ArticleId><ArticleId IdType="pmc">112746</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohm V, Seckert CK, Simon CO, Thomas D, Renzaho A, Gendig D, Holtappels R, Reddehase MJ. Immune evasion proteins enhance cytomegalovirus latency in the lungs. J Virol. 2009;83:10293&#x2013;8. https://doi.org/10.1128/JVI.01143-09 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01143-09</ArticleId><ArticleId IdType="pubmed">19605491</ArticleId><ArticleId IdType="pmc">2748014</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauwel B, Jang SM, Cassano M, Kapopoulou A, Barde I, Trono D. Release of human cytomegalovirus from latency by a KAP1/TRIM28 phosphorylation switch. Elife. 2015;4. https://doi.org/10.7554/eLife.06068 .</Citation></Reference><Reference><Citation>Liu XF, Yan S, Abecassis M, Hummel M. Establishment of murine cytomegalovirus latency in vivo is associated with changes in histone modifications and recruitment of transcriptional repressors to the major immediate-early promoter. J Virol. 2008;82:10922&#x2013;31. https://doi.org/10.1128/JVI.00865-08 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00865-08</ArticleId><ArticleId IdType="pubmed">18753203</ArticleId><ArticleId IdType="pmc">2573207</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu XF, Wang X, Yan S, Zhang Z, Abecassis M, Hummel M. Epigenetic control of cytomegalovirus latency and reactivation. Viruses. 2013;5:1325&#x2013;45. https://doi.org/10.3390/v5051325 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v5051325</ArticleId><ArticleId IdType="pubmed">23698401</ArticleId><ArticleId IdType="pmc">3712310</ArticleId></ArticleIdList></Reference><Reference><Citation>Groves IJ, Matthews SM, O&#x2019;Connor CM. Host-encoded CTCF regulates human cytomegalovirus latency via chromatin looping. Proc Natl Acad Sci U S A. 2024;121:e2315860121. https://doi.org/10.1073/pnas.2315860121 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2315860121</ArticleId><ArticleId IdType="pubmed">38408244</ArticleId><ArticleId IdType="pmc">10927566</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolich-Zugich J, Cicin-Sain L, Collins-McMillen D, Jackson S, Oxenius A, Sinclair J, Snyder C, Wills M, Lemmermann N. Advances in cytomegalovirus (CMV) biology and its relationship to health, diseases, and aging. Geroscience. 2020;42:495&#x2013;504. https://doi.org/10.1007/s11357-020-00170-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-020-00170-8</ArticleId><ArticleId IdType="pubmed">32162210</ArticleId><ArticleId IdType="pmc">7205956</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson SE, Redeker A, Arens R, van Baarle D, van den Berg SPH, Benedict CA, Cicin-Sain L, Hill AB, Wills MR. CMV immune evasion and manipulation of the immune system with aging. Geroscience. 2017;39:273&#x2013;91. https://doi.org/10.1007/s11357-017-9986-6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-017-9986-6</ArticleId><ArticleId IdType="pubmed">28647908</ArticleId><ArticleId IdType="pmc">5505894</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner TJ, Tortorella D. Virion glycoprotein-mediated immune evasion by human cytomegalovirus: a sticky virus makes a slick getaway. Microbiol Mol Biol Rev. 2016;80:663&#x2013;77. https://doi.org/10.1128/MMBR.00018-16 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00018-16</ArticleId><ArticleId IdType="pubmed">27307580</ArticleId><ArticleId IdType="pmc">4981668</ArticleId></ArticleIdList></Reference><Reference><Citation>Engel P, Angulo A. Viral immunomodulatory proteins: usurping host genes as a survival strategy. Adv Exp Med Biol. 2012;738:256&#x2013;76. https://doi.org/10.1007/978-1-4614-1680-7_15 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4614-1680-7_15</ArticleId><ArticleId IdType="pubmed">22399384</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandhu PK, Buchkovich NJ. Human Cytomegalovirus decreases major histocompatibility complex class II by regulating class II transactivator transcript levels in a myeloid cell line. J Virol. 2020;94. https://doi.org/10.1128/JVI.01901-19 .</Citation></Reference><Reference><Citation>Zhang Q, Song X, Ma P, Lv L, Zhang Y, Deng J, Zhang Y. Human cytomegalovirus miR-US33as-5p targets IFNAR1 to achieve immune evasion during both lytic and latent infection. Front Immunol. 2021;12:628364. https://doi.org/10.3389/fimmu.2021.628364 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.628364</ArticleId><ArticleId IdType="pubmed">33746965</ArticleId><ArticleId IdType="pmc">7973039</ArticleId></ArticleIdList></Reference><Reference><Citation>Zangger N, Oxenius A. T cell immunity to cytomegalovirus infection. Curr Opin Immunol. 2022;77:102185. https://doi.org/10.1016/j.coi.2022.102185 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2022.102185</ArticleId><ArticleId IdType="pubmed">35576865</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhry MZ, Casalegno-Garduno R, Sitnik KM, Kasmapour B, Pulm AK, Brizic I, Eiz-Vesper B, Moosmann A, Jonjic S, Mocarski ES, Cicin-Sain L. Cytomegalovirus inhibition of extrinsic apoptosis determines fitness and resistance to cytotoxic CD8 T cells. Proc Natl Acad Sci U S A. 2020;117:12961&#x2013;8. https://doi.org/10.1073/pnas.1914667117 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1914667117</ArticleId><ArticleId IdType="pubmed">32444487</ArticleId><ArticleId IdType="pmc">7293702</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W, Wang C, Ding M, Bian Y, Zhong Y, Shen H, Wang J, Zhang CY, Zhang C. Different expression pattern of human cytomegalovirus-encoded microRNAs in circulation from virus latency to reactivation. J Transl Med. 2020;18:469. https://doi.org/10.1186/s12967-020-02653-w .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02653-w</ArticleId><ArticleId IdType="pubmed">33298092</ArticleId><ArticleId IdType="pmc">7727131</ArticleId></ArticleIdList></Reference><Reference><Citation>Diggins NL, Skalsky RL, Hancock MH. Regulation of latency and reactivation by human cytomegalovirus miRNAs. Pathogens. 2021;10. https://doi.org/10.3390/pathogens10020200 .</Citation></Reference><Reference><Citation>Diggins NL, Hancock MH. HCMV miRNA targets reveal important cellular pathways for viral replication, latency, and reactivation. Noncoding RNA. 2018;4. https://doi.org/10.3390/ncrna4040029 .</Citation></Reference><Reference><Citation>Abdalla AE, Mahjoob MO, Abosalif KOA, Ejaz H, Alameen AAM, Elsaman T. Human cytomegalovirus-encoded microRNAs: a master regulator of latent infection. Infect Genet Evol. 2020;78:104119. https://doi.org/10.1016/j.meegid.2019.104119 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2019.104119</ArticleId><ArticleId IdType="pubmed">31740397</ArticleId></ArticleIdList></Reference><Reference><Citation>Sitnik KM, Krstanovic F, Godecke N, Rand U, Kubsch T, Maass H, Kim Y, Brizic I, Cicin-Sain L. Fibroblasts are a site of murine cytomegalovirus lytic replication and Stat1-dependent latent persistence in vivo. Nat Commun. 2023;14:3087. https://doi.org/10.1038/s41467-023-38449-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-38449-x</ArticleId><ArticleId IdType="pubmed">37248241</ArticleId><ArticleId IdType="pmc">10227055</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz M, Stern-Ginossar N. Rethinking human cytomegalovirus latency reservoir. Ann N Y Acad Sci. 2023;1524:30&#x2013;6. https://doi.org/10.1111/nyas.14994 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.14994</ArticleId><ArticleId IdType="pubmed">37026581</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddehase MJ, Lemmermann NAW. Cellular reservoirs of latent cytomegaloviruses. Med Microbiol Immunol. 2019;208:391&#x2013;403. https://doi.org/10.1007/s00430-019-00592-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-019-00592-y</ArticleId><ArticleId IdType="pubmed">31011793</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodrum F. The complex biology of human cytomegalovirus latency. Adv Virus Res. 2022;112:31&#x2013;85. https://doi.org/10.1016/bs.aivir.2022.01.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.aivir.2022.01.001</ArticleId><ArticleId IdType="pubmed">35840181</ArticleId></ArticleIdList></Reference><Reference><Citation>Damania B, Kenney SC, Raab-Traub N. Epstein-Barr virus: biology and clinical disease. Cell. 2022;185:3652&#x2013;70. https://doi.org/10.1016/j.cell.2022.08.026 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.08.026</ArticleId><ArticleId IdType="pubmed">36113467</ArticleId><ArticleId IdType="pmc">9529843</ArticleId></ArticleIdList></Reference><Reference><Citation>Draborg AH, Duus K, Houen G. Epstein-Barr virus and systemic lupus erythematosus. Clin Dev Immunol. 2012;2012:370516. https://doi.org/10.1155/2012/370516 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/370516</ArticleId><ArticleId IdType="pubmed">22811739</ArticleId><ArticleId IdType="pmc">3395176</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen KW, Wang L, Menke JR, Damania B. Cancers associated with human gammaherpesviruses. FEBS J. 2022;289:7631&#x2013;69. https://doi.org/10.1111/febs.16206 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.16206</ArticleId><ArticleId IdType="pubmed">34536980</ArticleId></ArticleIdList></Reference><Reference><Citation>Gloghini A, Dolcetti R, Carbone A. Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology. Semin Cancer Biol. 2013;23:457&#x2013;67. https://doi.org/10.1016/j.semcancer.2013.08.004 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2013.08.004</ArticleId><ArticleId IdType="pubmed">23999127</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhagavathi S, Wilson JD. Primary central nervous system lymphoma. Arch Pathol Lab Med. 2008;132:1830&#x2013;4. https://doi.org/10.5858/132.11.1830 .</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/132.11.1830</ArticleId><ArticleId IdType="pubmed">18976024</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornevik K, Munz C, Cohen JI, Ascherio A. Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. Nat Rev Neurol. 2023;19:160&#x2013;71. https://doi.org/10.1038/s41582-023-00775-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-023-00775-5</ArticleId><ArticleId IdType="pubmed">36759741</ArticleId></ArticleIdList></Reference><Reference><Citation>Dioverti MV, Razonable RR. Cytomegalovirus. Microbiol Spectr. 2016;4. https://doi.org/10.1128/microbiolspec.DMIH2-0022-2015 .</Citation></Reference><Reference><Citation>Mason GM, Jackson S, Okecha G, Poole E, Sissons JG, Sinclair J, Wills MR. Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4(+) T cells. PLoS Pathog. 2013;9: e1003635. https://doi.org/10.1371/journal.ppat.1003635 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003635</ArticleId><ArticleId IdType="pubmed">24130479</ArticleId><ArticleId IdType="pmc">3795018</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills MR, Poole E, Lau B, Krishna B, Sinclair JH. The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies? Cell Mol Immunol. 2015;12:128&#x2013;38. https://doi.org/10.1038/cmi.2014.75 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2014.75</ArticleId><ArticleId IdType="pubmed">25132454</ArticleId></ArticleIdList></Reference><Reference><Citation>Keymeulen A, De Leenheer E, Casaer A, Cossey V, Laroche S, Mahieu L, Oostra A, Van Mol C, Dhooge I, Smets K. Neurodevelopmental outcome in children with congenital cytomegalovirus infection: a prospective multicenter cohort study. Early Hum Dev. 2023;182:105777. https://doi.org/10.1016/j.earlhumdev.2023.105777 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.earlhumdev.2023.105777</ArticleId><ArticleId IdType="pubmed">37187139</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheeran MC, Lokensgard JR, Schleiss MR. Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev. 2009;22:99&#x2013;126, Table of Contents. https://doi.org/10.1128/CMR.00023-08 .</Citation></Reference><Reference><Citation>Shim GH. Treatment of congenital cytomegalovirus infection. Clin Exp Pediatr. 2023;66:384&#x2013;94. https://doi.org/10.3345/cep.2022.01032 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3345/cep.2022.01032</ArticleId><ArticleId IdType="pubmed">36596746</ArticleId></ArticleIdList></Reference><Reference><Citation>Akpan US, Pillarisetty LS. Congenital cytomegalovirus infection. In: StatPearls. Treasure Island (FL). StatPearls Publishing. 2024. https://www.ncbi.nlm.nih.gov/books/NBK541003/ . Accessed 07/08/2024.</Citation></Reference><Reference><Citation>Pantry SN, Medveczky PG. Latency, integration, and reactivation of human herpesvirus-6. Viruses. 2017;9. https://doi.org/10.3390/v9070194.</Citation></Reference><Reference><Citation>Agut H, Bonnafous P, Gautheret-Dejean A. Human herpesviruses 6A, 6B, and 7. Microbiol Spectr. 2016;4. https://doi.org/10.1128/microbiolspec.DMIH2-0007-2015 .</Citation></Reference><Reference><Citation>Whitley RJ. Herpesviruses. In: Baron S, ed. Medical Microbiology. Galveston (TX); 1996.</Citation></Reference><Reference><Citation>Becerra A, Gibson L, Stern LJ, Calvo-Calle JM. Immune response to HHV-6 and implications for immunotherapy. Curr Opin Virol. 2014;9:154&#x2013;61. https://doi.org/10.1016/j.coviro.2014.10.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2014.10.001</ArticleId><ArticleId IdType="pubmed">25462448</ArticleId></ArticleIdList></Reference><Reference><Citation>Eliassen E, Hemond CC, Santoro JD. HHV-6-associated neurological disease in children: epidemiologic, clinical, diagnostic, and treatment considerations. Pediatr Neurol. 2020;105:10&#x2013;20. https://doi.org/10.1016/j.pediatrneurol.2019.10.004 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2019.10.004</ArticleId><ArticleId IdType="pubmed">31932119</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartolini L, Theodore WH, Jacobson S, Gaillard WD. Infection with HHV-6 and its role in epilepsy. Epilepsy Res. 2019;153:34&#x2013;9. https://doi.org/10.1016/j.eplepsyres.2019.03.016 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eplepsyres.2019.03.016</ArticleId><ArticleId IdType="pubmed">30953871</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariza ME. Myalgic encephalomyelitis/chronic fatigue syndrome: the human herpesviruses are back!. Biomolecules. 2021;11. https://doi.org/10.3390/biom11020185 .</Citation></Reference><Reference><Citation>Petrakopoulou P, Kubrich M, Pehlivanli S, Meiser B, Reichart B, von Scheidt W, Weis M. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function. Circulation. 2004;110:II207&#x2013;212. https://doi.org/10.1161/01.CIR.0000138393.99310.1c .</Citation></Reference><Reference><Citation>Leskov IL, Whitsett J, Vasquez-Vivar J, Stokes KY. NAD(P)H oxidase and eNOS play differential roles in cytomegalovirus infection-induced microvascular dysfunction. Free Radic Biol Med. 2011;51:2300&#x2013;8. https://doi.org/10.1016/j.freeradbiomed.2011.09.039 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2011.09.039</ArticleId><ArticleId IdType="pubmed">22033010</ArticleId><ArticleId IdType="pmc">3272703</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes JM, Kell DB, Pretorius E. Herpesvirus infection of endothelial cells as a systemic pathological axis in myalgic encephalomyelitis/chronic fatigue syndrome. Viruses. 2024;16. https://doi.org/10.3390/v16040572 .</Citation></Reference><Reference><Citation>Reinhardt B, Godfrey R, Fellbrich G, Frank H, Luske A, Olieslagers S, Mertens T, Waltenberger J. Human cytomegalovirus infection impairs endothelial cell chemotaxis by disturbing VEGF signalling and actin polymerization. Cardiovasc Res. 2014;104:315&#x2013;25. https://doi.org/10.1093/cvr/cvu204 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvu204</ArticleId><ArticleId IdType="pubmed">25228663</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimura T, Aomura D, Harada M, Yamaguchi A, Yamaka K, Nakajima T, Tanaka N, Ehara T, Hashimoto K, Kamijo Y. Investigation of clinical features and association between vascular endothelial injury markers and cytomegalovirus infection associated with thrombotic microangiopathy in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: case-based research. Int J Mol Sci. 2024;25. https://doi.org/10.3390/ijms25020812 .</Citation></Reference><Reference><Citation>Lebedeva A, Maryukhnich E, Grivel JC, Vasilieva E, Margolis L, Shpektor A. Productive cytomegalovirus infection is associated with impaired endothelial function in ST-elevation myocardial infarction. Am J Med. 2020;133:133&#x2013;42. https://doi.org/10.1016/j.amjmed.2019.06.021 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2019.06.021</ArticleId><ArticleId IdType="pubmed">31295440</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerna G, Lilleri D, Fornara C, d&#x2019;Angelo P, Baldanti F. Relationship of human cytomegalovirus-infected endothelial cells and circulating leukocytes in the pathogenesis of disseminated human cytomegalovirus infection: a narrative review. Rev Med Virol. 2024;34: e2496. https://doi.org/10.1002/rmv.2496 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2496</ArticleId><ArticleId IdType="pubmed">38282408</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Wilson A, Alber S, Ma Z, Tang ZL, Satoh E, Mazda O, Watkins S, Huang L, Pitt B, Li S. Prolonged gene expression in mouse lung endothelial cells following transfection with Epstein-Barr virus-based episomal plasmid. Gene Ther. 2003;10:822&#x2013;6. https://doi.org/10.1038/sj.gt.3301958 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.gt.3301958</ArticleId><ArticleId IdType="pubmed">12704423</ArticleId><ArticleId IdType="pmc">7091729</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong A, Clarke-Katzenberg RH, Valenzuela G, Izumi KM, Millan MT. Epstein-Barr virus latent membrane protein 1 activates nuclear factor-kappa B in human endothelial cells and inhibits apoptosis. Transplantation. 2004;78:41&#x2013;9. https://doi.org/10.1097/01.tp.0000129805.02631.ef .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.tp.0000129805.02631.ef</ArticleId><ArticleId IdType="pubmed">15257037</ArticleId></ArticleIdList></Reference><Reference><Citation>Indari O, Tiwari D, Tanwar M, Kumar R, Jha HC. Early biomolecular changes in brain microvascular endothelial cells under Epstein-Barr virus influence: a Raman microspectroscopic investigation. Integr Biol (Camb). 2022;14:89&#x2013;97. https://doi.org/10.1093/intbio/zyac009 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intbio/zyac009</ArticleId><ArticleId IdType="pubmed">35780312</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalpke AH, Thomssen R, Ritter K. Oxidative injury to endothelial cells due to Epstein-Barr virus-induced autoantibodies against manganese superoxide dismutase. J Med Virol. 2003;71:408&#x2013;16. https://doi.org/10.1002/jmv.10501 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.10501</ArticleId><ArticleId IdType="pubmed">12966547</ArticleId></ArticleIdList></Reference><Reference><Citation>Casiraghi C, Dorovini-Zis K, Horwitz MS. Epstein-Barr virus infection of human brain microvessel endothelial cells: a novel role in multiple sclerosis. J Neuroimmunol. 2011;230:173&#x2013;7. https://doi.org/10.1016/j.jneuroim.2010.08.003 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2010.08.003</ArticleId><ArticleId IdType="pubmed">20826008</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CA, Shanley JD. Chronic infection of human umbilical vein endothelial cells by human herpesvirus-6. J Gen Virol. 1998;79(Pt 5):1247&#x2013;56. https://doi.org/10.1099/0022-1317-79-5-1247 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-79-5-1247</ArticleId><ArticleId IdType="pubmed">9603340</ArticleId></ArticleIdList></Reference><Reference><Citation>Takatsuka H, Wakae T, Mori A, Okada M, Fujimori Y, Takemoto Y, Okamoto T, Kanamaru A, Kakishita E. Endothelial damage caused by cytomegalovirus and human herpesvirus-6. Bone Marrow Transplant. 2003;31:475&#x2013;9. https://doi.org/10.1038/sj.bmt.1703879 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bmt.1703879</ArticleId><ArticleId IdType="pubmed">12665843</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso A, Rotola A, Comar M, Favilli F, Galvan M, Tosetti M, Campello C, Caselli E, Alessandri G, Grassi M, et al. HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines. J Med Virol. 2002;67:528&#x2013;33. https://doi.org/10.1002/jmv.10133 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.10133</ArticleId><ArticleId IdType="pubmed">12115999</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor S, Taylor C, Campbell LA, Epstein S, Libby P. Potential infectious etiologies of atherosclerosis: a multifactorial perspective. Emerg Infect Dis. 2001;7:780&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0705.010503</ArticleId><ArticleId IdType="pubmed">11747688</ArticleId><ArticleId IdType="pmc">2631877</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison MAA, Morris SL, Rudman GA, Rittenhouse DJ, Monk CH, Sakamuri S, Mehedi Hasan M, Shamima Khatun M, Wang H, Garfinkel LP, et al. Intermittent cytomegalovirus infection alters neurobiological metabolism and induces cognitive deficits in mice. Brain Behav Immun. 2024;117:36&#x2013;50. https://doi.org/10.1016/j.bbi.2023.12.033 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.12.033</ArticleId><ArticleId IdType="pubmed">38182037</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcendor DJ, Charest AM, Zhu WQ, Vigil HE, Knobel SM. Infection and upregulation of proinflammatory cytokines in human brain vascular pericytes by human cytomegalovirus. J Neuroinflammation. 2012;9:95. https://doi.org/10.1186/1742-2094-9-95 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-9-95</ArticleId><ArticleId IdType="pubmed">22607552</ArticleId><ArticleId IdType="pmc">3413582</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcendor DJ. Human vascular pericytes and cytomegalovirus pathobiology. Int J Mol Sci. 2019;20. https://doi.org/10.3390/ijms20061456 .</Citation></Reference><Reference><Citation>Kelkar AH, Loc BL, Tarantino MD, Rajasekhar A, Wang H, Kelkar M, Farrell J. Cytomegalovirus-associated venous and arterial thrombotic disease. Cureus. 2020;12:e12161. https://doi.org/10.7759/cureus.12161 .</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.12161</ArticleId><ArticleId IdType="pubmed">33489573</ArticleId><ArticleId IdType="pmc">7813978</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubio Nazabal E, Alvarez Perez P, Lema Facal T, Sanchez VE. Cerebral venous sinus thrombosis and portal vein thrombosis associated with acute cytomegalovirus infection in an immunocompetent patient. Enferm Infecc Microbiol Clin (Engl Ed). 2023;41:380&#x2013;1. https://doi.org/10.1016/j.eimce.2023.04.004 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eimce.2023.04.004</ArticleId><ArticleId IdType="pubmed">37085444</ArticleId></ArticleIdList></Reference><Reference><Citation>King C, Patel R, Mendoza C, Walker JK, Wu EY, Moss P, Morgan MD, O&#x2019;Dell Bunch D, Harper L, Chanouzas D. Cytomegalovirus infection is a risk factor for venous thromboembolism in ANCA-associated vasculitis. Arthritis Res Ther. 2022;24:192. https://doi.org/10.1186/s13075-022-02879-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-022-02879-7</ArticleId><ArticleId IdType="pubmed">35948984</ArticleId><ArticleId IdType="pmc">9364516</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallbracht KB, Schwimmbeck PL, Kuhl U, Seeberg B, Schultheiss HP. Endothelium-dependent flow-mediated vasodilation of systemic arteries is impaired in patients with myocardial virus persistence. Circulation. 2004;110:2938&#x2013;45. https://doi.org/10.1161/01.CIR.0000146891.31481.CF .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000146891.31481.CF</ArticleId><ArticleId IdType="pubmed">15505098</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono T, Iwasaki T, Terada Y, Mori Y, Nejima R, Ozaki M, Mochizuki M, Miyata K. Long-term outcome in corneal endotheliitis with molecular detection of herpes simplex virus 1 and human herpes virus 6: a case report. BMC Ophthalmol. 2022;22:48. https://doi.org/10.1186/s12886-022-02274-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12886-022-02274-5</ArticleId><ArticleId IdType="pubmed">35105322</ArticleId><ArticleId IdType="pmc">8808982</ArticleId></ArticleIdList></Reference><Reference><Citation>Indari O, Chandramohanadas R, Jha HC. Epstein-Barr virus infection modulates blood-brain barrier cells and its co-infection with Plasmodium falciparum induces RBC adhesion. Pathog Dis. 2021;79. https://doi.org/10.1093/femspd/ftaa080 .</Citation></Reference><Reference><Citation>Das N, Das J, Pal D. Stromal and endothelial herpes simplex virus keratitis reactivation in the convalescent period of COVID-19 - a case report. Indian J Ophthalmol. 2022;70:1410&#x2013;2. https://doi.org/10.4103/ijo.IJO_2838_21 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijo.IJO_2838_21</ArticleId><ArticleId IdType="pubmed">35326068</ArticleId><ArticleId IdType="pmc">9240579</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoeger T, Adler H. &#x201c;Novel&#x201d; triggers of herpesvirus reactivation and their potential health relevance. Front Microbiol. 2018;9:3207. https://doi.org/10.3389/fmicb.2018.03207 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.03207</ArticleId><ArticleId IdType="pubmed">30666238</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomasini RL, Pereira DS, Pereira FSM, Mateo EC, Mota TN, Guimaraes GG, Pereira LSM, Lima CX, Teixeira MM, Teixeira ALJ. Aged-associated cytomegalovirus and Epstein-Barr virus reactivation and cytomegalovirus relationship with the frailty syndrome in older women. PLoS ONE. 2017;12:e0180841. https://doi.org/10.1371/journal.pone.0180841 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0180841</ArticleId><ArticleId IdType="pubmed">28700679</ArticleId><ArticleId IdType="pmc">5507269</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KA, Flores RR, Jang IH, Saathoff A, Robbins PD. Immune senescence, immunosenescence and aging. Front Aging. 2022;3:900028. https://doi.org/10.3389/fragi.2022.900028 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fragi.2022.900028</ArticleId><ArticleId IdType="pubmed">35821850</ArticleId><ArticleId IdType="pmc">9261375</ArticleId></ArticleIdList></Reference><Reference><Citation>Tassaneeyasin T, Sungkanuparph S, Srichatrapimuk S, Charoensri A, Thammavaranucupt K, Jayanama K, Kirdlarp S. Prevalence and risk factors of cytomegalovirus reactivation in critically Ill patients with COVID-19 pneumonia. PLoS ONE. 2024;19:e0303995. https://doi.org/10.1371/journal.pone.0303995 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0303995</ArticleId><ArticleId IdType="pubmed">38771836</ArticleId><ArticleId IdType="pmc">11108163</ArticleId></ArticleIdList></Reference><Reference><Citation>Talukder S, Deb P, Parveen M, Zannat KE, Bhuiyan AH, Yeasmin M, Molla MMA, Saif-Ur-Rahman KM. Clinical features and outcomes of COVID-19 patients with concomitant herpesvirus co-infection or reactivation: a systematic review. New Microbes New Infect. 2024;58:101233. https://doi.org/10.1016/j.nmni.2024.101233 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2024.101233</ArticleId><ArticleId IdType="pubmed">38425457</ArticleId><ArticleId IdType="pmc">10901905</ArticleId></ArticleIdList></Reference><Reference><Citation>Payen SH, Adhikari K, Petereit J, Uppal T, Rossetto CC, Verma SC. SARS-CoV-2 superinfection in CD14(+) monocytes with latent human cytomegalovirus (HCMV) promotes inflammatory cascade. Virus Res. 2024;345:199375. https://doi.org/10.1016/j.virusres.2024.199375 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2024.199375</ArticleId><ArticleId IdType="pubmed">38642618</ArticleId><ArticleId IdType="pmc">11061749</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattei A, Schiavoni L, Riva E, Ciccozzi M, Veralli R, Urselli A, Citriniti V, Nenna A, Pascarella G, Costa F, et al. Epstein-Barr virus, cytomegalovirus, and herpes simplex-1/2 reactivations in critically ill patients with COVID-19. Intensive Care Med Exp. 2024;12:40. https://doi.org/10.1186/s40635-024-00624-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40635-024-00624-9</ArticleId><ArticleId IdType="pubmed">38649512</ArticleId><ArticleId IdType="pmc">11035506</ArticleId></ArticleIdList></Reference><Reference><Citation>Grubelnik G, Korva M, Kogoj R, Polanc T, Mavric M, Jevsnik Virant M, Ursic T, Kese D, Seme K, Petrovec M, et al. Herpesviridae and atypical bacteria co-detections in lower respiratory tract samples of SARS-CoV-2-positive patients admitted to an intensive care unit. Microorganisms. 2024;12. https://doi.org/10.3390/microorganisms12040714 .</Citation></Reference><Reference><Citation>Haddad M, Sheybani F, Olfati N, Nahayati MA, Boostani R, Layegh P, Rashid-Nejad A. Central nervous system reactivation of herpesviridae family in patients with COVID-19. J Neurovirol. 2023;29:211&#x2013;7. https://doi.org/10.1007/s13365-023-01132-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-023-01132-4</ArticleId><ArticleId IdType="pubmed">37097596</ArticleId><ArticleId IdType="pmc">10127951</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacconi R, Cardelli M, Piacenza F, Pierpaoli E, Farnocchia E, Di Rosa M, Bonfigli AR, Casoli T, Marchegiani F, Marcheselli F, et al. Effect of cytomegalovirus reactivation on inflammatory status and mortality of older COVID-19 patients. Int J Mol Sci. 2023;24. https://doi.org/10.3390/ijms24076832 .</Citation></Reference><Reference><Citation>Bernal KDE, Whitehurst CB. Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients. Virus Res. 2023;334:199157. https://doi.org/10.1016/j.virusres.2023.199157 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2023.199157</ArticleId><ArticleId IdType="pubmed">37364815</ArticleId><ArticleId IdType="pmc">10292739</ArticleId></ArticleIdList></Reference><Reference><Citation>Banko A, Miljanovic D, Cirkovic A. Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: old players on the new field. Int J Infect Dis. 2023;130:108&#x2013;25. https://doi.org/10.1016/j.ijid.2023.01.036 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.01.036</ArticleId><ArticleId IdType="pubmed">36736577</ArticleId><ArticleId IdType="pmc">9889115</ArticleId></ArticleIdList></Reference><Reference><Citation>Reizine F, Liard C, Pronier C, Thibault V, Maamar A, Gacouin A, Tadie JM. Herpesviridae systemic reactivation in patients with COVID-19-associated ARDS. J Hosp Infect. 2022;119:189&#x2013;91. https://doi.org/10.1016/j.jhin.2021.11.007 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2021.11.007</ArticleId><ArticleId IdType="pubmed">34800612</ArticleId></ArticleIdList></Reference><Reference><Citation>Lino K, Alves LS, Raposo JV, Medeiros T, Souza CF, Silva AAD, de Paula VS, Almeida JR. Presence and clinical impact of human herpesvirus-6 infection in patients with moderate to critical coronavirus disease-19. J Med Virol. 2022;94:1212&#x2013;6. https://doi.org/10.1002/jmv.27392 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27392</ArticleId><ArticleId IdType="pubmed">34647632</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Song J, Dai L, Post SR, Qin Z. SARS-CoV-2 infection and lytic reactivation of herpesviruses: a potential threat in the postpandemic era? J Med Virol. 2022;94:5103&#x2013;11. https://doi.org/10.1002/jmv.27994 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27994</ArticleId><ArticleId IdType="pubmed">35819034</ArticleId><ArticleId IdType="pmc">9350099</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B, Tancredi C, Song Y, Mogus AT, Huang MW, Zhu H, Phan TL, Zhu H, Kadl A, Woodfolk J, et al. Epstein-Barr virus and human herpesvirus-6 reactivation in acute COVID-19 patients. Viruses. 2022;14. https://doi.org/10.3390/v14091872 .</Citation></Reference><Reference><Citation>Chen T, Song J, Liu H, Zheng H, Chen C. Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients. Sci Rep. 2021;11:10902. https://doi.org/10.1038/s41598-021-90351-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90351-y</ArticleId><ArticleId IdType="pubmed">34035353</ArticleId><ArticleId IdType="pmc">8149409</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber S, Kehl V, Erber J, Wagner KI, Jetzlsperger AM, Burrell T, Schober K, Schommers P, Augustin M, Crowell CS, et al. CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients. PLoS ONE. 2022;17:e0268530. https://doi.org/10.1371/journal.pone.0268530 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0268530</ArticleId><ArticleId IdType="pubmed">35613127</ArticleId><ArticleId IdType="pmc">9132318</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer DS, Ansari M, Wagner KI, Jarosch S, Huang Y, Mayr CH, Strunz M, Lang NJ, D&#x2019;Ippolito E, Hammel M, et al. Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through &#x2018;reverse phenotyping.&#x2019; Nat Commun. 2021;12:4515. https://doi.org/10.1038/s41467-021-24730-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24730-4</ArticleId><ArticleId IdType="pubmed">34312385</ArticleId><ArticleId IdType="pmc">8313584</ArticleId></ArticleIdList></Reference><Reference><Citation>Frozza FTB, Fazolo T, de Souza PO, Lima K, da Fontoura JC, Borba TS, Polese-Bonatto M, Kern LB, Stein RT, Pawelec G, Bonorino C. A high CMV-specific T cell response associates with SARS-CoV-2-specific IL-17 T cell production. Med Microbiol Immunol. 2023;212:75&#x2013;91. https://doi.org/10.1007/s00430-022-00758-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-022-00758-1</ArticleId><ArticleId IdType="pubmed">36512097</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Hollmann C, Kalanidhi S, Grothey A, Keating S, Mena-Palomo I, Lamer S, Schlosser A, Kaiping A, Scheller C, et al. Increased circulating fibronectin, depletion of natural IgM and heightened EBV, HSV-1 reactivation in ME/CFS and long COVID. medRxiv. 2023. https://doi.org/10.1101/2023.06.23.23291827 .</Citation></Reference><Reference><Citation>Muller L, Di Benedetto S. Immunosenescence and cytomegalovirus: exploring their connection in the context of aging, health, and disease. Int J Mol Sci. 2024;25. https://doi.org/10.3390/ijms25020753 .</Citation></Reference><Reference><Citation>Molnar T, Lehoczki A, Fekete M, Varnai R, Zavori L, Erdo-Bonyar S, Simon D, Berki T, Csecsei P, Ezer E. Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches. Geroscience. 2024. https://doi.org/10.1007/s11357-024-01165-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-024-01165-5</ArticleId><ArticleId IdType="pubmed">39138793</ArticleId><ArticleId IdType="pmc">11336094</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba T, Connors JM, Levy JH. What role does microthrombosis play in long COVID? Semin Thromb Hemost. 2023. https://doi.org/10.1055/s-0043-1774795 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0043-1774795</ArticleId><ArticleId IdType="pubmed">37748518</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Ibn Hadj Amor H, Jdidi J, Torjmen S, Kraiem S, Hammami R, Bahloul A, Kallel N, Moussa N, Touil I, et al. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Front Cardiovasc Med. 2021;8:745758. https://doi.org/10.3389/fcvm.2021.745758 .</Citation></Reference><Reference><Citation>Flaskamp L, Roubal C, Uddin S, Sotzny F, Kedor C, Bauer S, Scheibenbogen C, Seifert M. Serum of post-COVID-19 syndrome patients with or without ME/CFS differentially affects endothelial cell function in vitro. Cells. 2022;11. https://doi.org/10.3390/cells11152376 .</Citation></Reference><Reference><Citation>Williams Ph DM, Cox B, Lafuse Ph DW, Ariza ME. Epstein-Barr Virus dUTPase induces neuroinflammatory mediators: implications for myalgic encephalomyelitis/chronic fatigue syndrome. Clin Ther. 2019;41:848&#x2013;63. https://doi.org/10.1016/j.clinthera.2019.04.009 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2019.04.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox BS, Alharshawi K, Mena-Palomo I, Lafuse WP, Ariza ME. EBV/HHV-6A dUTPases contribute to myalgic encephalomyelitis/chronic fatigue syndrome pathophysiology by enhancing TFH cell differentiation and extrafollicular activities. JCI Insight. 2022;7. https://doi.org/10.1172/jci.insight.158193 .</Citation></Reference><Reference><Citation>Domingues TD, Grabowska AD, Lee JS, Ameijeiras-Alonso J, Westermeier F, Scheibenbogen C, Cliff JM, Nacul L, Lacerda EM, Mourino H, Sepulveda N. Herpesviruses serology distinguishes different subgroups of patients from the United Kingdom myalgic encephalomyelitis/chronic fatigue syndrome biobank. Front Med (Lausanne). 2021;8:686736. https://doi.org/10.3389/fmed.2021.686736 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.686736</ArticleId><ArticleId IdType="pubmed">34291062</ArticleId></ArticleIdList></Reference><Reference><Citation>Shikova E, Reshkova V, Kumanova capital AC, Raleva S, Alexandrova D, Capo N, Murovska M, On Behalf Of The European Network On Me/Cfs E. Cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic small ie, cyrillicncephalomyelitis/chronic fatigue syndrome. J Med Virol. 2020;92:3682&#x2013;3688. https://doi.org/10.1002/jmv.25744 .</Citation></Reference><Reference><Citation>Schreiner P, Harrer T, Scheibenbogen C, Lamer S, Schlosser A, Naviaux RK, Prusty BK. Human herpesvirus-6 reactivation, mitochondrial fragmentation, and the coordination of antiviral and metabolic phenotypes in myalgic encephalomyelitis/chronic fatigue syndrome. Immunohorizons. 2020;4:201&#x2013;15. https://doi.org/10.4049/immunohorizons.2000006 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/immunohorizons.2000006</ArticleId><ArticleId IdType="pubmed">32327453</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg J, Rizwan M, Bohlin-Wiener A, Elfaitouri A, Julin P, Zachrisson O, Rosen A, Gottfries CG. Antibodies to human herpesviruses in myalgic encephalomyelitis/chronic fatigue syndrome patients. Front Immunol. 2019;10:1946. https://doi.org/10.3389/fimmu.2019.01946 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01946</ArticleId><ArticleId IdType="pubmed">31475007</ArticleId><ArticleId IdType="pmc">6702656</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapenko S, Krumina A, Logina I, Rasa S, Chistjakovs M, Sultanova A, Viksna L, Murovska M. Association of active human herpesvirus-6, -7 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Adv Virol. 2012;2012:205085. https://doi.org/10.1155/2012/205085 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/205085</ArticleId><ArticleId IdType="pubmed">22927850</ArticleId><ArticleId IdType="pmc">3426163</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams GP, Yu ED, Shapiro K, Wang E, Freuchet A, Frazier A, Lindestam Arlehamn CS, Sette A, da Silva AR. Investigating viral and autoimmune T cell responses associated with post-acute sequelae of COVID-19. Hum Immunol. 2024;85:110770. https://doi.org/10.1016/j.humimm.2024.110770 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2024.110770</ArticleId><ArticleId IdType="pubmed">38433036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Pablos M, Paiva B, Zabaleta A. Epstein-Barr virus-acquired immunodeficiency in myalgic encephalomyelitis-Is it present in long COVID? J Transl Med. 2023;21:633. https://doi.org/10.1186/s12967-023-04515-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-04515-7</ArticleId><ArticleId IdType="pubmed">37718435</ArticleId><ArticleId IdType="pmc">10506247</ArticleId></ArticleIdList></Reference><Reference><Citation>Manoharan S, Ying LY. Epstein Barr virus reactivation during COVID-19 hospitalization significantly increased mortality/death in SARS-CoV-2(+)/EBV(+) than SARS-CoV-2(+)/EBV(-) patients: a comparative meta-analysis. Int J Clin Pract. 2023;2023:1068000. https://doi.org/10.1155/2023/1068000 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/1068000</ArticleId><ArticleId IdType="pubmed">36793928</ArticleId><ArticleId IdType="pmc">9904914</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunn AVW, Guy GW, Botchway SW, Bell JD. SARS-CoV-2 and EBV; the cost of a second mitochondrial &#x201c;whammy&#x201d;? Immun Ageing. 2021;18:40. https://doi.org/10.1186/s12979-021-00252-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-021-00252-x</ArticleId><ArticleId IdType="pubmed">34717676</ArticleId><ArticleId IdType="pmc">8556816</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoeggerl AD, Nunhofer V, Lauth W, Badstuber N, Held N, Zimmermann G, Grabmer C, Weidner L, Jungbauer C, Lindlbauer N, et al. Epstein-Barr virus reactivation is not causative for post-COVID-19-syndrome in individuals with asymptomatic or mild SARS-CoV-2 disease course. BMC Infect Dis. 2023;23:800. https://doi.org/10.1186/s12879-023-08820-w .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08820-w</ArticleId><ArticleId IdType="pubmed">37968601</ArticleId><ArticleId IdType="pmc">10652630</ArticleId></ArticleIdList></Reference><Reference><Citation>Skuja S, Svirskis S, Murovska M. Human herpesvirus-6 and -7 in the brain microenvironment of persons with neurological pathology and healthy people. Int J Mol Sci. 2021;22. https://doi.org/10.3390/ijms22052364 .</Citation></Reference><Reference><Citation>Williams MV, Cox B, Ariza ME. Herpesviruses dUTPases: a new family of pathogen-associated molecular pattern (PAMP) proteins with implications for human disease. Pathogens. 2016;6. https://doi.org/10.3390/pathogens6010002 .</Citation></Reference><Reference><Citation>Wakefield D, Lloyd A, Dwyer J, Salahuddin SZ, Ablashi DV. Human herpesvirus 6 and myalgic encephalomyelitis. Lancet. 1988;1:1059. https://doi.org/10.1016/s0140-6736(88)91885-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(88)91885-5</ArticleId><ArticleId IdType="pubmed">2896906</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingues TD, Malato J, Grabowska AD, Lee JS, Ameijeiras-Alonso J, Biecek P, Graca L, Mourino H, Scheibenbogen C, Westermeier F, et al. Association analysis between symptomology and herpesvirus IgG antibody concentrations in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and multiple sclerosis. Heliyon. 2023;9:e18250. https://doi.org/10.1016/j.heliyon.2023.e18250 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e18250</ArticleId><ArticleId IdType="pubmed">37519635</ArticleId><ArticleId IdType="pmc">10372404</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltsev D. A comparative study of valaciclovir, valganciclovir, and artesunate efficacy in reactivated HHV-6 and HHV-7 infections associated with chronic fatigue syndrome/myalgic encephalomyelitis. Microbiol Immunol. 2022;66:193&#x2013;9. https://doi.org/10.1111/1348-0421.12966 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1348-0421.12966</ArticleId><ArticleId IdType="pubmed">35102619</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>